Journey Medical Corp - Common Stock (DERM) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2021 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
DERM on Nasdaq
Shares outstanding
17,194,910
Price per share
$8.00
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
6,094,703
Total reported value
$46,989,842
% of total 13F portfolios
0%
Share change
+715,017
Value change
+$5,523,150
Number of holders
50
Price from insider filings
$8.00
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Journey Medical Corp - Common Stock (DERM) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
TANG CAPITAL MANAGEMENT LLC 8% $14,020,746 1,854,596 TANG CAPITAL MANAGEMENT, LLC 31 Mar 2025
WASATCH ADVISORS LP 6.7% +26% $7,972,248 +$1,532,476 1,152,059 +24% WASATCH ADVISORS LP 30 Jun 2025

As of 31 Dec 2025, 50 institutional investors reported holding 6,094,703 shares of Journey Medical Corp - Common Stock (DERM). This represents 35% of the company’s total 17,194,910 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Journey Medical Corp - Common Stock (DERM) together control 34% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
WASATCH ADVISORS LP 7.7% 1,316,275 +0.77% 0.06% $10,148,480
VANGUARD GROUP INC 4.4% 764,147 +24% 0% $5,891,574
BlackRock, Inc. 4.2% 719,784 +14% 0% $5,549,535
Pale Fire Capital SE 2.6% 444,642 +95% 0.44% $3,428,190
Summit Financial, LLC 2.3% 390,419 +2.8% 0.04% $3,010,130
ESSEX INVESTMENT MANAGEMENT CO LLC 2% 345,977 -2.3% 0.41% $2,667,483
GEODE CAPITAL MANAGEMENT, LLC 1.8% 313,970 +13% 0% $2,420,885
UBS Group AG 1.7% 290,226 +100% 0% $2,237,642
RENAISSANCE TECHNOLOGIES LLC 1.4% 244,000 -1.6% 0% $1,881,240
AMERICAN FINANCIAL GROUP INC 1% 180,000 0% 0.5% $1,387,800
STATE STREET CORP 1% 173,337 +19% 0% $1,336,428
Legato Capital Management LLC 0.65% 111,695 +9.6% 0.07% $861,168
SEI INVESTMENTS CO 0.64% 109,351 0% $843,096
Informed Momentum Co LLC 0.52% 89,389 0% 0.08% $689,189
Geneos Wealth Management Inc. 0.37% 63,280 0% 0.01% $487,889
Diametric Capital, LP 0.3% 51,683 0.11% $398,475
PVG ASSET MANAGEMENT CORP 0.3% 51,632 -61% 0.85% $398,082
Integrated Wealth Concepts LLC 0.26% 44,020 -0.74% 0% $339,396
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.21% 35,507 +17% 0% $273,759
ENVESTNET ASSET MANAGEMENT INC 0.2% 33,594 -45% 0% $259,010
Bank of New York Mellon Corp 0.17% 28,738 +17% 0% $221,567
BNP PARIBAS FINANCIAL MARKETS 0.16% 27,819 0% 0% $214,484
MORGAN STANLEY 0.15% 26,500 +28% 0% $204,315
BARCLAYS PLC 0.13% 22,521 +28% 0% $173,637
Focus Partners Wealth 0.11% 19,710 0% $151,964

Institutional Holders of Journey Medical Corp - Common Stock (DERM) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 6,094,703 $46,989,842 +$5,523,150 $7.71 50
2025 Q3 8,692,790 $61,930,042 +$15,659,236 $7.12 67
2025 Q2 6,494,302 $46,629,314 +$11,145,137 $7.18 56
2025 Q1 5,017,760 $29,603,817 +$7,390,927 $5.90 38
2024 Q4 3,813,405 $14,909,751 +$6,149,987 $3.91 38
2024 Q3 2,156,982 $12,186,357 -$1,194,242 $5.65 36
2024 Q2 2,360,259 $13,310,203 +$3,384,583 $5.64 35
2024 Q1 1,816,385 $6,678,973 +$973,921 $3.68 31
2023 Q4 1,341,390 $7,982,763 -$492,957 $5.76 34
2023 Q3 2,135,266 $5,850,655 +$1,401,524 $2.74 20
2023 Q2 1,652,825 $2,627,537 -$24,753 $1.59 19
2023 Q1 1,668,350 $2,620,320 -$179,207 $1.57 16
2022 Q4 2,672,478 $5,131,893 -$313,986 $1.92 18
2022 Q3 1,878,524 $4,621,000 +$328,580 $2.46 18
2022 Q2 1,759,431 $6,580,100 +$289,703 $3.74 12
2022 Q1 1,644,289 $7,940,000 +$35,914 $4.83 13
2021 Q4 1,627,492 $8,756,000 +$8,756,000 $5.38 14